GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » YoY EBITDA Growth

M1 Kliniken AG (XTER:M12) YoY EBITDA Growth : 37.13% (As of Jun. 2023)


View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. M1 Kliniken AG's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was 37.13%.

M1 Kliniken AG's EBITDA per Share for the six months ended in Jun. 2023 was €0.51.


M1 Kliniken AG YoY EBITDA Growth Historical Data

The historical data trend for M1 Kliniken AG's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG YoY EBITDA Growth Chart

M1 Kliniken AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 2.95 79.77 -20.17 42.42 -18.58

M1 Kliniken AG Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 105.05 -15.38 -39.41 1.62 37.13

M1 Kliniken AG YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

M1 Kliniken AG's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(0.872-1.071)/ | 1.071 |
=-18.58 %

M1 Kliniken AG's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(0.506-0.369)/ | 0.369 |
=37.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


M1 Kliniken AG YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


M1 Kliniken AG (XTER:M12) Business Description

Traded in Other Exchanges
Address
Grunauer strasse 5, Berlin, BB, DEU, 12557
M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.
Executives
Kilian Brenske Board of Directors
Attila Strauss Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines